Crossmark

Therapeutic effects of chitooligosaccharide-epigallocatechin gallate conjugate on NAFLD: impact on gut-liver axis, lipid metabolism, and inflammation in rats fed a high-fat diet

Crossref DOI link: https://doi.org/10.1007/s13105-026-01193-z

Published Online: 2026-05-30

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mueangaun, Sirikul

Tonphu, Kanokrada

Lerkdumnernkit, Natcha

Sengking, Jirakhamon

Tocharus, Jiraporn

Benjakul, Soottawat

Tocharus, Chainarong
Funding

Funding for this research was provided by:

National Research Council of Thailand (Grant No N41A640207)

National Research Council of Thailand (Grant No. N42A670596)
License Information

Text and Data Mining valid from 2026-05-30

Version of Record valid from 2026-05-30
More Information

Article History

Received: 3 February 2026

Accepted: 9 May 2026

First Online: 30 May 2026

Declarations

:

: The Institutional Animal Care and Use Committee of the Faculty of Medicine, Chiang Mai University, in accordance with the National Institutes of Health (NIH) Guidelines, approved the study (Protocol approval number: 07/2565).

: The authors declare no competing interests.

: Not applicable.

Document is current

Any future updates will be listed below